Close Menu

NEW YORK – Engineering biology startup Sherlock Biosciences has been awarded two new grants in the last two months that will help the company develop its twin technology platforms, SHERLOCK and INSPECTR, into the foundation for new diagnostic tests that can be used in just about any environment or circumstance.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.